Sign In
Buy CLRB
$2.57
+0.0400 (+1.58%)
At Close: Jul 31, 2026
Why Energy Stocks Traded Higher; Here Are 61 Biggest Movers From Yesterday
09:32am, Tuesday, 26'th Jul 2022 Benzinga
Gainers
GeoVax Labs, Inc. (NASDAQ: GOVX) jumped 150.4% to close at $1.59 on Monday after declining 8% on Friday.
Redbox Entertainment Inc. (NASDAQ: RDBX) shares climbed 82% to close at $5.55 on Mon
Why Is Infrastructure and Energy Alternatives Higher By Around 29%? 37 Stocks Moving In Monday's Mid-Day Session
04:36pm, Monday, 25'th Jul 2022 Benzinga
Gainers
Revelation Biosciences, Inc. (NASDAQ: REVB) jumped 104% to $1.3263 after the company announced that primary endpoint was met in study for its treatment of allergic rhinitis.
Redbox Entertainm
Cellectar Announces Stock Consolidation
08:15pm, Thursday, 21'st Jul 2022 GlobeNewswire Inc.
FLORHAM PARK, N.J., July 21, 2022 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB), a late-stage biopharmaceutical company focused on the discovery, development and commercialization o
Why Is United Airlines Down By Over 6%? Here Are 25 Stocks Moving In Thursday's Pre-Market Session
09:53am, Thursday, 21'st Jul 2022 Benzinga
Gainers
Tuesday Morning Corporation (NASDAQ: TUEM) rose 72.1% to $0.3420 in pre-market trading after dipping 30% on Wednesday. Tuesday Morning recently announced partnership with Intalytics for custo
Why Baker Hughes Shares Dropped 8%; Here Are 64 Biggest Movers From Yesterday
08:40am, Thursday, 21'st Jul 2022 Benzinga
Gainers
Pagaya Technologies Ltd. (NASDAQ: PGY) shares climbed 129.6% to close at $6.20 on Wednesday. Pagaya Technologies is expected to announce its Q2 earnings on August 16, 2022.
Direct Digital Ho
Cellectar Reports Financial Results for First Quarter 2022 and Provides a Corporate Update
12:30pm, Tuesday, 10'th May 2022 GlobeNewswire Inc.
FLORHAM PARK, N.J., May 10, 2022 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercial
Here's Why Cellectar Biosciences Shares Are Rising
01:32pm, Monday, 21'st Mar 2022
Cellectar Biosciences Inc (NASDAQ: CLRB) shares are trading higher by 12.1% at $0.61 after the company reported better-than-expected fourth-quarter EPS results. Cellectar Biosciences beat estimated
Cellectar Reports Financial Results for Year Ended December 2021 and Provides a Corporate Update
12:30pm, Monday, 21'st Mar 2022 GlobeNewswire Inc.
FLORHAM PARK, N.J., March 21, 2022 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commerci
Cellectar to Participate at Upcoming Banking Conferences
09:05pm, Thursday, 10'th Mar 2022 GlobeNewswire Inc.
FLORHAM PARK, N.J., March 10, 2022 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development, and commerc
Cellectar Biosciences appoints Chad Kolean as CFO, Jarrod Longcor as COO
01:44pm, Wednesday, 23'rd Feb 2022 Seeking Alpha
Cellectar Biosciences (CLRB) names Mr. Chad Kolean as Chief Financial Officer and promoted Mr. Jarrod Longcor to the role of Chief Operating Officer. Mr
Is CanFite Biopharma Ltd (CANF) Outperforming Other Medical Stocks This Year?
02:40pm, Monday, 17'th Jan 2022 Zacks Investment Research
Here is how CanFite Biopharma Ltd (CANF) and Cellectar Biosciences, Inc. (CLRB) have performed compared to their sector so far this year.
Zacks.com featured highlights include: RentACenter, U.S. Physical Therapy, Cellectar Biosciences, Toro and Zymeworks
12:40pm, Monday, 17'th Jan 2022 Zacks Investment Research
RentACenter, U.S. Physical Therapy, Cellectar Biosciences, Toro and Zymeworks are highlighted in this Screen of the Week article.
Ride on Rising P/E Investing With These 5 Top-Ranked Stocks
11:27am, Friday, 14'th Jan 2022 Zacks Investment Research
Want to try an out-of-the-box approach? Tap five stocks with increasing P/E ratios.
Ride on Rising P/E Investing With These 5 Top-Ranked Stocks
07:46am, Friday, 14'th Jan 2022
Want to try an out-of-the-box approach? Tap five stocks with increasing P/E ratios.
Cellectar to Participate in Fireside Chat at the H.C. Wainwright Bioconnect Conference
01:30pm, Tuesday, 04'th Jan 2022 GlobeNewswire Inc.
FLORHAM PARK, N.J., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercia
